Iguana Healthcare Partners seeks maximum capital appreciation from investing long/short globally in public companies in the healthcare industry.

Iguana's broad base of investment opportunities includes pharmaceuticals, biotechnology, medical devices, diagnostics, healthcare services and healthcare information technology. Our research strategy is bottom-up and stock-by-stock and will focus on innovation and pharmaco-economics as a driver of sales and earnings growth. Global and sector-specific risk will be actively managed with an eye on capital preservation.

The firm was named Iguana, as iguanas have demonstrated the ability to evolve and thrive in changing environments throughout the world and over the millennium.